Member Exclusive Peek behind the paper

Peek behind the paper: real-world data concerning the efficacy of osimertinib in a subset of NSCLC patients

In this feature, we peek behind the paper with contributing study author Filippo de Marinis (European Institute of Oncology, Milan, Italy): the ASTRIS study.

Go to the profile of The Evidence Base
Oct 28, 2019
0
0

Please sign in or register for FREE

No comments yet.